Search research articles
Contact Us
Filters
Showing results (41-50 of 149) with videos related to
Page
of 15
Sort By:
Plos One
|
September 10, 2015
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens
Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Oncology
|
July 8, 2011
Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation
Kaoru Tsuchiya, Mina Komuta, Yutaka Yasui, et al.
Plos One
|
September 15, 2015
Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy
Jun Itakura, Masayuki Kurosaki, Mayu Higuchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 24, 2013
Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy
Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Nakanishi, et al.
Journal of Gastroenterology
|
January 4, 2021
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study
Masatoshi Kudo, Kaoru Tsuchiya, Naoya Kato, et al.
Liver Cancer
|
May 7, 2025
Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150
Masatoshi Kudo, Tatsuya Yamashita, Richard S Finn, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 23, 2011
Changes in hepatitis C viral load during first 14 days can predict the undetectable time point of serum viral load by pegylated interferon and ribavirin therapy
Jun Itakura, Yasuhiro Asahina, Nobuharu Tamaki, et al.
World Journal of Gastroenterology
|
January 25, 2013
Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy
Takanori Hosokawa, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 11, 2015
Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group
Kouji Joko, Tohru Goto, Hiroshi Watanabe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 16, 2014
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 149) with videos related to
Sort By:
Page
of 15
Plos One
|
September 10, 2015
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens
Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Oncology
|
July 8, 2011
Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation
Kaoru Tsuchiya, Mina Komuta, Yutaka Yasui, et al.
Plos One
|
September 15, 2015
Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy
Jun Itakura, Masayuki Kurosaki, Mayu Higuchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 24, 2013
Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy
Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Nakanishi, et al.
Journal of Gastroenterology
|
January 4, 2021
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study
Masatoshi Kudo, Kaoru Tsuchiya, Naoya Kato, et al.
Liver Cancer
|
May 7, 2025
Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150
Masatoshi Kudo, Tatsuya Yamashita, Richard S Finn, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 23, 2011
Changes in hepatitis C viral load during first 14 days can predict the undetectable time point of serum viral load by pegylated interferon and ribavirin therapy
Jun Itakura, Yasuhiro Asahina, Nobuharu Tamaki, et al.
World Journal of Gastroenterology
|
January 25, 2013
Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy
Takanori Hosokawa, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 11, 2015
Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group
Kouji Joko, Tohru Goto, Hiroshi Watanabe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 16, 2014
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Page
of 15